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tightly linked structure and function.[1] 
However, it is still unknown whether 
the presynaptic bouton adapts its shape 
during functional plasticity. Indeed, obser-
vation of the presynaptic bouton typically 
requires visualization methods based on 
super-resolution microscopy (SRM). For 
dynamic studies, the major bottleneck of 
SRM techniques is the time required to 
obtain sufficient information to recon-
struct membrane shapes with accept-
able accuracy, which is usually of tens of 
minutes, precluding then the use of this 
technique to image more rapid events.
Single molecule localization micro-
scopy (SMLM) belongs to the recently 
developed SRM modalities for fluorescent 
probes whose spatial and temporal reso-
lution gives now access to domains and 
events of biological relevance.[2,3] At large, 
SMLM has been applied to the transla-
tion of fluorescence emission intensities 
into spatial coordinates, thereby enabling 
single-particle tracking with unprec-
edented detail.[4] In cell biology, SMLM 
has found numerous applications tracking 
the dynamics of cell membrane compo-
nents,[5–7] intracellular structures,[8–12] endocytic pathways,[13,14] 
among others. In particular, point accumulation for imaging 
in nanoscale topography (PAINT) modalities have emerged 
as a powerful and versatile technique to reconstruct super-
resolved images of biomolecular structures and cell mem-
branes.[15–18] This technique relies on the super-localization of 
individual fluorophores bound to the target of interest. These 
Single-particle tracking with quantum dots (QDs) constitutes a powerful tool 
to track the nanoscopic dynamics of individual cell membrane components 
unveiling their membrane diffusion characteristics. Here, the nano-resolved 
population dynamics of QDs is exploited to reconstruct the topography and 
structural changes of the cell membrane surface with high temporal and 
spatial resolution. For this proof-of-concept study, bright, small, and stable 
biofunctional QD nanoconstructs are utilized recognizing the endogenous 
neuronal cannabinoid receptor 1, a highly expressed and fast-diffusing 
membrane protein, together with a commercial point-localization microscope. 
Rapid QD diffusion on the axonal plasma membrane of cultured hippocampal 
neurons allows precise reconstruction of the membrane surface in less than 
1 min with a spatial resolution of tens of nanometers. Access of the QD nano-
constructs to the synaptic cleft enables rapid 3D topological reconstruction 
of the entire presynaptic component. Successful reconstruction of membrane 
nano-topology and deformation at the second time-scale is also demon-
strated for HEK293 cell filopodia and axons. Named “nanoPaint,” this super-
resolution imaging technique amenable to any endogenous transmembrane 
target represents a versatile platform to rapidly and accurately reconstruct 
the cell membrane nano-topography, thereby enabling the study of the rapid 
dynamic phenomena involved in neuronal membrane plasticity.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/smll.201902796.
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1. Introduction
The surface topology of many cell types is continuously 
adapting to intracellular and extracellular cues. In neurons, 
rapid structural modification of the synapse, the relay of neu-
ronal information, is one of the fundamental processes of 
learning and memory. This was shown in dendritic spines, the 
typical postsynaptic component in excitatory synapses, with 
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will eventually photobleach and be replaced by a large pool 
of free, unbound fluorophores present in the solution. How-
ever, the dynamics of exchange between photobleached and 
new, unbleached probes is slow. This process can be acceler-
ated by increasing the concentration of free probes in solution, 
though this increases the fluorescent background and eventu-
ally prohibits the detection of isolated bound fluorophores. In 
practice, fully reconstructed images often require several tens 
of minutes of acquisition, thereby preventing the study of fast 
dynamic events. This limitation may be lifted using Förster res-
onance energy transfer–based probes,[19] though at the expense 
of adding two fluorophores, complex antibody-DNA constructs, 
and finely tuned complementary strands. Noteworthy, this tech-
nique has so far only been demonstrated for fixed cells.[20–22]
The use of quantum dot (QD) nanoparticles as alterna-
tive fluorescent probes in highly sensitive biological imaging 
has witnessed major advances, with the QDs becoming 
instrumental in several SRM techniques due to their intrinsic 
brightness, enhanced photostability, broad excitation, narrow, 
and tunable emission wavelengths.[3,23–26] By combining SRM 
with brilliant and robust fluorescent probes as the QDs, it is 
possible to follow the rapid dynamics of cell membrane com-
ponents, like receptors or transporters, with high temporal 
and spatial resolution. Cumulative integration of the spatial 
localizations of rapid co-diffusing ligand-target pairs in the 
3D-fluid cell membrane has the potential to enable the recon-
struction of the plasma membrane morphology and the follow-
up of its dynamic changes in nanoscopic cellular volumes. 
Such approach was recently used to create a diffusion and 
morphological map of the axonal initial segment[27] and of den-
dritic spines.[9] However, these studies relied on probes that 
require the genetic expression of a green fluorescent protein 
(GFP) tag on the target molecule followed by the addition of 
either QDs-streptavidin-anti-GFP (biotin) nanoconstructs[27] 
or a primary plus secondary biotinylated antibodies and then 
QDs-streptavidin.[9] To our knowledge, the application of these 
methods to track an endogenous receptor, the use of nano-
probes suitable to label any cell membrane biomolecule without 
the need for transfection and the rapid (seconds) reconstruction 
of the cell membrane in 3D has not been demonstrated yet.
In this work, our previously developed biofunctional QD 
nanoconstructs,[28] now adapted to target the cannabinoid 
receptor 1 (CB1), a rapidly diffusing cell membrane protein,[29] 
are utilized as “painting” agents in SRM to rapidly draw the 
cell membrane in 3D with nanoscopic resolution. Named 
“nanoPaint,” this method is amenable to track the dynamics 
of endogenous cell membrane biomolecules and has proved 
instrumental to map the topography and morphological 
changes of cell membranes. In opposition to DNA-PAINT 
methods, nanoPaint does not involve a transiently bound asso-
ciation: the binding between antibody and protein is strong; the 
QD molecular pencils remain photostable and associated to the 
target even when the latter is internalized. Furthermore, theo-
retical modeling indicates that the extent of the topographic 
reconstruction of cell membranes throughout a defined time 
period depends upon the surface density of the nanoconstructs, 
which is easily controlled by tuning the concentration of the 
nanoprobes in the cell medium. Thanks to the capacity of the 
nanoconstructs to access and diffuse into the synaptic cleft, 
nanoPaint made it possible to rapidly draw (in less than 1 min) 
a nanoscopic 3D map of the presynapses and of the synaptic 
cleft. Insights of spontaneous, nanometric membrane deforma-
tion lasting seconds in HEK-293 cells and in neurons add ver-
satility to the nanoPaint method and highlight its potential as a 
precision tool for neuronal plasticity studies.
2. Results and Discussion
The red-emitting (λem = 650 nm) CdSe/CdS/ZnS multishell 
QDs employed in this work were synthesized following pub-
lished protocols.[30,31] These inorganic nanoparticles are capped 
with a vinylimidazole-sulfobetaine copolymer ligand that bears 
primary amine side chains to be used for bioconjugation.[28] 
These QD nanoparticles demonstrated: a) high colloidal 
stability and a conserved photoluminescence in the pH range 
7–12; b) minimal nonspecific interactions with cells in culture; 
and c) a remarkable colloidal stability in the cell cytoplasm after 
electroporation and follow-up for ≈50 h.[28] Such properties are 
vital in proposing these nanoprobes as tools for biological/
cellular investigations as they ensure minimal nonspecific 
interactions with the cell membrane and with nontargeted 
species. To render these nanoparticles bio-specific, the oriented 
immobilization of whole antibodies via an intermediate protein 
A layer was developed.[28] Once the protein A layer is bound to 
the nanoparticles, the resulting QDs-pA nanoconstructs are 
kept in pH 7.5 buffer at 4 °C and utilized as needed to bind to 
selected antibodies (Ab) simply by mixing at a 1:4 QD:Ab molar 
ratio. These QD-protein A (QD-pA) nanoconstructs (Figure 1a) 
thus constitute a universal platform for the oriented immobi-
lization of whole antibodies, thereby providing unrestricted 
versatility to the nanoPaint approach since Abs can be raised 
against most transmembrane proteins such as receptors, or 
other membrane-confined biomolecules.
For the proof-of-concept demonstration of the nano-
Paint method, the CB1 receptor was used as cell membrane 
target. The CB1 receptor, the brain target of marijuana and 
endocannabinoid ligands, is one of the most abundant G 
protein- coupled receptors in the brain, well recognized for its 
capacity to modulate synaptic plasticity and neuronal develop-
ment.[32,33] The CB1 receptor has been shown to constitutively 
cycle between cell membrane and cytoplasm via the endocytic 
pathway.[34] In simple terms, this cycling results in mem-
brane receptors being internalized over time and accumu-
lating in cellular endosomes while others are re-cycled from 
the endosomes to the cell membrane. In neurons, this cycling 
is necessary for the axonal targeting of the receptor, which is 
first expressed in the somato-dendritic compartment, endocy-
tosed, and actively transported by transcytosis into the axonal 
compartment where it resides on the cell membrane.[35] As 
a result, the CB1 receptor has a highly polarized distribution 
and is mainly found in axons; it is therefore an excellent mem-
brane marker of the axonal and presynaptic compartments. 
Both, single molecule tracking and fluorescence recovery 
after photobleaching (FRAP) methods,[29,35] have indicated 
high membrane diffusion rates for the CB1 receptor, making 
it a useful reporter for PAINT approaches. In this study, we 
employed nanoconstructs recognizing either the endogenous 
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Figure 1. QD-pA nanoconstructs are versatile nanoprobes for the study of the dynamics of cell membrane proteins. a) Schematic representation of 
the biofunctional, fluorescent QD nanoconstructs employed to “paint” the cell membrane. The nanoconstructs are composed of an inorganic core 
(QD) surface-covered by a vinylimidazole-sulfobetaine copolymer ligand. QD-pA nanoconstructs are obtained by reaction of ligand primary amines and 
protein A, which in turn enables the oriented immobilization of target-recognition IgG antibodies. b) Illustration of the two cases considered in this 
work: QDs-anti-FLAG used to target the extracellular FLAG tag corresponding to the over-expressed CB1 transmembrane receptor with intracellular 
GFP fluorescent terminus (left) and QDs-anti-CB1 employed to target the endogenous CB1 receptor (right), both in live cell experiments. c) Wide-field 
epifluorescence images of the FLAG-CB1-GFP and QD channels, their overlay, and the maximal projection over a 2 min acquisition time (0.5 fps). Note 
that biofunctional QDs allow visualization of the majority of neurites with only 2 min of acquisition. d) Two neurites from panel (c) (labeled 1, 2) were 
selected for the kymographs on the GFP (green) and QD (magenta) channels. The Brownian diffusion of QDs is clearly visible in the kymographs, 
while GFP kymographs are blurrier and appear more static.
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CB1 receptor or the heterogenously expressed FLAG-CB1-GFP 
fusion protein[34,36] (Figure 1b). Expression of the fluorescently 
tagged CB1 receptor ensured facile recognition of receptor-
expressing neurons and provided a control to evaluate the spec-
ificity of recognition of the CB1 receptor by the biofunctional 
QDs. On the other hand, the endogenous form was allowed to 
confidently evaluate and monitor receptor behavior and its rela-
tionship with neuronal membrane plasticity without putative 
over-expression artifacts. We therefore started with the over-
expressed receptor and moved toward the endogenous one. The 
FLAG-CB1-GFP and endogenous CB1 receptors were detected 
with anti-FLAG and anti-CB1 Abs, respectively (Figure 1b). 
The QD-Ab bioconjugates resulting from binding of the anti-
FLAG Ab to QD-pA nanoconstructs had an overall diameter 
of ≈27 nm and possessed 1–2 fully functional Abs per dot.[28] 
Noteworthy, the size of the nanotools can be modulated by 
decreasing the size of the target-recognition species (e.g., using 
antibody fragments instead of whole antibodies) or avoiding 
the use of protein A and directly binding the target-recognition 
species to the QD ligand.
Throughout this work, typical experiments involved the 
exposure of primary cultures of rat hippocampal neurons to 
diluted (1–3 × 10−9 m) suspensions of QD bioconjugates fol-
lowed by microscopic monitoring either on a wide-field epifluo-
rescence microscope (Figure 1) or on a commercial point-local-
ization microscope (Figures 2–4). One of the first insights of 
the notorious difference between single-particle tracking obser-
vations with QDs compared to GFP-expressing receptors was 
obtained by tracing kymographs depicting the temporal move-
ment of both, QD nanoconstructs bound to FLAG-CB1-GFP 
receptors and the GFP receptor’s tag (Figure 1b and Figure S1, 
Supporting Information). Kymographs, which depict the posi-
tion and signal intensity variations of an emitter as a function 
of time, highlight distinct patterns (Figure 1d): QDs produce 
trace patterns of receptor movement that are sharp, oscillatory, 
and well contrasted compared to the surrounding areas thanks 
to QDs’ salient brilliance and to the fact that, at short times 
after the addition of the nanoconstructs, only a subpopulation 
of the membrane CB1 receptors is bound to the QDs (Figure 1c 
and Video S1, Supporting Information, QD panel as opposed 
to the FLAG-CB1-GFP panel). Being able to tune the QD con-
centration in the cell medium results in a subpopulation of 
the receptor to be tracked, thus facilitating single-particle anal-
ysis. GFP-related kymographs, on the other hand, highlight 
only GFP clusters present in endosomes since the green GFP 
signal is homogenous and widespread on the cell membrane 
(Figure 1c, FLAG-CB1-GFP panel) and can therefore not be 
identified as a single-particle object by current analytical tools. 
Finally, the maximal projection of the 2 min long recording 
(Figure 1c) showed that the majority of neurites have been 
completely covered by the QD localizations, suggesting that the 
PAINT[15] method using over-expressed CB1 receptors can effi-
ciently draw the membrane surface in less than 2 min.
Having previously demonstrated the specific recognition of 
the CB1 receptor by the QD bioconjugates[28] and the high dif-
fusion of the QDs bound to receptors at the plasma membrane 
in the wide-field epifluorescence experiments above, we moved 
to SRM for single-particle tracking at high spatio-temporal res-
olution. The aim was to go beyond single-particle tracking by 
exploiting its wealth of particle trajectories to reconstruct the 
cell membrane in nearly real time, in 3D and with nanoscale 
resolution. Noteworthy, since the QD solution is not removed 
from the cell medium, there is a continuous availability of QD 
nanoconstructs to newly exocytosed CB1 receptors. This allows 
to follow receptor population dynamics over sufficiently long 
periods of time (≈hours) without photobleaching as well as to 
Small 2019, 15, 1902796
Figure 2. Dissecting the nanoPaint principle: superposition of QD localizations over time generates gradual reconstructions of the cell membrane 
topology. In this example, 21 000 frames (336 s) were sufficient to satisfactorily reconstruct the cell membrane in areas 1 and 2 (rows labeled 1 and 2, 
respectively). QD-pA-anti-FLAG nanoconjugates labeling FLAG-CB1-GFP expressing neurons were employed.
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tune the surface density of QDs over time by adjusting the QD 
solution concentration. Importantly, the experiments reported 
here were carried out under highly inclined thin illumination,[37] 
implying that the excitation of the QDs can be tuned to thin 
sections containing the structure to be reconstructed. In addi-
tion, the fast acquisition rate of 16 ms per frame ensured that 
only receptor-bound QDs displaying a slower diffusion coef-
ficient (as compared to the free QDs in the medium) will be 
recognized as single particles by the detection algorithm.[16]
With the nanoPaint approach and by superimposing QD’s 
localizations, a sequential reconstruction of the cell membrane 
as “explored” by the nanoconstructs can be rapidly obtained 
(Figure 2). Increasing the acquisition time (i.e., the number of 
16 ms frames whose individual spatial localizations are super-
imposed) substantially increases surface coverage, allowing to 
reconstitute the shape and location of entire filopods or syn-
aptic boutons, as demonstrated below. This wealth of informa-
tion is independent of the ad hoc optimization of fluorescent 
probes (such as those required for photo-activated localization 
microscopy microscopy), the reliance on cell fixation or on very 
laborious techniques like transmission electron microscopy 
(TEM), both prone to introduce artifacts,[38,39] or the need for 
preincubation steps with antibodies prior QDs’ introduction.[9] 
The nanoPaint method uniquely relies on the use of QD nano-
constructs of tunable fluorescence emission bioconjugated to 
primary antibodies. These very bright fluorescent nanocon-
structs permit a lateral resolution below 55 nm as measured 
by Fourier ring correlation[40] (Figure S5, Supporting Informa-
tion) and an axial resolution of 85 nm as measured by fiduciary 
markers (QDs unspecifically bound to the coverslip). Conse-
quently, the nanoPaint method may thus serve both single-
particle tracking as well as surface reconstruction purposes.
The efficacy of cell surface reconstruction depends both, on 
the number of QDs whose trajectories are being followed and 
on the acquisition frequency (number of frames per second). 
In our experience, in particular for transfected cells, surface 
coverage also depends on the transfection rate and the specific 
cellular sub-compartment imaged (soma, dendrites, or axons). 
Finally, surface coverage also depends on the total area to be 
reconstructed: as observed in Figure 2, there are areas on the 
full field of view that appear less well reconstructed than others 
depending on whether the cell membrane itself and/or the 
QD nanoconstructs that are possibly “painting” that area are 
close to the focal plane or not. In general, assuming a random, 
uncorrelated motion of QDs, the reconstructed area fraction f is 
given by Equation (1), where d is the QD surface density and A1 
is the area reconstructed by one QD
= − −f e dA1 1  (1)
Assuming a 2D Brownian motion of the QDs on the cell sur-
face, simulations show that the reconstructed area A1 depends 
on the diffusion coefficient D and on the time (Figure S2a,b, 
Supporting Information). For slowly diffusing QDs, A1 ini-
tially increases with D, then saturates when the mean-square 
displacement between two consecutive images becomes larger 
than the resolution of the reconstructed trajectory (Figure S2b, 
Supporting Information). After reconstructing diffusion tra-
jectories of single anti-FLAG QDs targeting FLAG-CB1-GFP 
transmembrane receptors, we obtained an average diffusion 
coefficient D ≈ 0.19 µm2 s−1 (165 000 reconstructed dis-
placements). This is consistent with a previous estimation of 
0.175 µm2 s−1 obtained by single-particle tracking in cultured 
neurons.[29] With this diffusion coefficient, simulations predict 
that the reconstructed fraction should follow an exponential law 
with time (Figure S2c, Supporting Information, Equation (2)). 
The characteristic reconstruction time τ depends on the QD 
density, d, with τ ≈ 58 d−1 (s µm2) assuming a 20 nm reconstruc-
tion resolution and a 16 ms time lag between two consecutive 
acquisitions
f t e t1 /( ) ≈ − τ−  (2)
In both, regions of interest (ROIs) presented as examples in 
Figure 2, the QD density was approximately 0.2 µm−2. These 
membrane surfaces should then be theoretically reconstructed 
at 50% in about 185 s (Figure S2d, Supporting Information). As 
shown in Figure 2, this theoretical estimation is consistent with 
experimental observations. While these simulations enable 
the estimation of the average reconstruction time for a given 
target density, the final membrane reconstruction speed relies 
on random QD blinking and on stochastic Brownian motion 
in each specific ROI. We can predict that, at this reconstruc-
tion resolution, faster diffusion coefficients would not strongly 
improve the reconstruction speed (Figure S2b, Supporting 
Information). However, increasing the QD density strongly 
does (Equation (1); Figure S2c,d, Supporting Information) 
and, assuming that target density is not a limiting factor, this 
is easily implemented by increasing QD concentration in the 
cell medium. As an example, with a diffusion coefficient of 
0.19 µm2 s−1 and a QD density of 1 µm−2, on average 50% of 
the membrane should be reconstructed in 39 s, and 80% in 
90 s (always assuming a 20 nm reconstruction resolution and 
16 ms time lag between two consecutive acquisitions). Nev-
ertheless, in practical terms, QD density cannot be increased 
indefinitely with the intention to reconstruct faster. The limit 
is single particle tracking, i.e., the capacity of the tracking algo-
rithms to identify QDs as single emitters.
Once the cell surface reconstruction capacity of the nano-
Paint method was demonstrated and the effect of the recon-
struction parameters was theoretically analyzed, we investigated 
whether QDs-anti-FLAG bound to over-expressed FLAG-CB1-
GFP receptors were able to access and explore the synaptic 
cleft area (Figure 3). The localization of the synaptic region was 
confirmed by the expression of tdTomato-Bassoon. Bassoon is a 
large multi-domain protein of the presynaptic active zone that 
identifies the presynaptic component.[41,42] Super-resolution 
point accumulation of QD trajectories around the areas of high 
Bassoon expression reveals a high frequency of visit for the QD 
nanoconstructs accessing the synaptic cleft (note the brighter 
regions at the active zones) as well as a remarkable reconstruc-
tion of the contours of presynaptic boutons (Figure 3a). With 
the addition of a cylindrical lens, it is possible to generate in 
5 min a 3D image of the synaptic boutons and the synaptic cleft 
that matches other representations of the same areas obtained 
by more laborious techniques, such as TEM[43] (Figure 3b and 
Video S2, Supporting Information). Since surface reconstruc-
tion of a given cell membrane region is dependent on its 
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effective surface “exploration” by the biofunctional QDs during 
live cell imaging, it is noteworthy that our ≈27 nm in diameter 
QD nanoconstructs appropriately accessed and explored the 
synaptic cleft. In a pioneering work, Dahan et al. demonstrated 
that slightly larger QD bioconjugates (QD-streptavidin bound to 
a secondary plus primary antibody) targeting glycine receptors 
could be detected in the synaptic cleft, where they possessed 
smaller coefficients of diffusion as compared to the extra-
synaptic QDs.[5] On the other hand, a recent study comparing 
different sizes of nanoconstructs recognizing the postsynaptic 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(which has an extracellular domain of 12 nm) showed that steric 
impairment hampers the accessibility and diffusion of large 
QD-streptavidin nanoconstructs (>20 nm in diameter) into the 
synaptic cleft.[44] Recognizing the relatively small extracellular 
domain of the CB1 receptor, our biofunctional QDs appear to 
be small enough to access and effectively map the entire topog-
raphy of presynaptic boutons in mature synapses.
Since rapid, 3D cell surface reconstruction can be obtained 
with nanoPaint, we tested the method for its capability to 
record structural plasticity at a nanoscale level and with a time 
resolution below 1 min, a relevant scale for rapid cytoskeletal 
changes. At first, we tested nanoPaint in a model cell line 
(HEK-293 cells) expressing the FLAG-CB1-GFP[36] receptor 
and for which we had previously demonstrated the binding 
specificity of the QDs-pA-anti-FLAG nanoconstructs.[28] We 
recorded filopodia (small organelles known to display a highly 
dynamic behavior) close to the glass surface and obtained defor-
mation profiles as those illustrated in Figure 4a by a 320 s time 
projection. The higher magnification shows two consecutive 
Small 2019, 15, 1902796
Figure 3. From 2D to 3D cell membrane reconstruction with nanoPaint: by using a cylindrical lens, temporal integration (5 min) of QD localizations 
around a presynaptic terminal enabled cell membrane reconstruction, both in 2D (a, right) and 3D (b). a) A schematic representation of the synaptic 
bouton and the synaptic cleft (the gap between pre- and postsynaptic areas) is presented (left) together with the post- and presynaptic regions. The 
localization of the synaptic region is confirmed by the presence of tdTomato-Bassoon, a presynaptic marker of the active zone (middle). b) Membrane 
reconstruction at different z planes with a depth of 40 nm. For a whole 3D image, see Video S2 in the Supporting Information. Transfected neurons 
expressing FLAG-CB1-GFP and tdTomato-Bassoon and QD-pA-anti-FLAG nanoconjugates were employed.
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reconstructions of 16 s (1000 frames) in green and in magenta 
of a filopodium, with a cross-section of 200 nm as measured by 
the distance between the two peaks of intensity of the plasma 
membrane. Moreover, the y-z cross-section indicates that 
the membrane reconstruction was also efficient in 3D since 
the reconstruction is covering almost the entire depth of the 
Small 2019, 15, 1902796
Figure 4. Nanoscopic structural plasticity of the cell membrane as revealed by nanoPaint. a) Dynamic reconstruction of the plasma membrane of HEK-293 
cells expressing the FLAG-CB1-GFP receptor “nanoPainted” with QDs-pA-anti-FLAG nanoconjugates. On the top left, the color code encodes the temporal 
reconstruction over 320 s. The filopodium on the dashed box is reconstructed in the lower left panel at a higher magnification during the first 16 s (green) 
and the following 16–32 s (magenta). The dashed white line represents the plan of the orthogonal y-z view showed in the upper right panel. The profile 
intensity (down right) indicates a shift of the filopodium tip of 85 nm. b) nanoPaint with QDs-pA-anti-CB1 on hippocampal neurons (50 days in vitro) 
that were reconstructed and color-coded into five time-lapses of 80 s each. The merged image shows different regions in which spontaneous structural 
changes have occurred. Four regions were selected for a higher magnification. c) Cell membrane deformation due to phototoxicity in hippocampal 
neurons exposed to high laser power excitation. Four nonconsecutive time lapses of 32 s each are presented (right) together with a merged image (left).
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filopodium; only the bottom is not visited by the QDs, probably 
due to their difficulty to access this region which is close to the 
coverslip. The overlay of the two consecutive 16 s reconstruc-
tions reveals that the filopodium is elongating and bending 
at the tip during this time period. To quantify the structural 
modification, we measured the distance between both recon-
structions by tracing a line scan profile and recorded a 85 nm 
shift of the tip between the two consecutive 16 s recordings. 
The nanoPaint method is thus able to rapidly and accurately 
measure nanoscopic deformations of plasma membrane-delim-
ited organelles such as filopodia.
Next, we evaluated the membrane surface mapping capacity 
of the nanoPaint method by targeting the endogenous CB1 
receptor in nontransfected hippocampal neurons. It was a 
requirement to prove at first the specificity of binding of the QD-
pA-anti-CB1 nanoconstructs to the endogenous CB1 receptor. 
As observed in Figure S3a in the Supporting Information, the 
endogenous receptor is highly enriched in axons although it 
is also ubiquitously present in the plasma membrane of the 
somato-dendritic compartment, as previously reported.[35] The 
same can be confirmed for the QD-pA-anti-CB1 nanoconstructs 
(Figure S3b, Supporting Information), with an overlap coeffi-
cient of 0.85.[45] By employing QDs recognizing the endogenous 
CB1 receptor, spontaneous membrane deformations could be 
recorded in hippocampal neurons with nanometric precision 
and methodological simplicity (Figure 4b). Interestingly, the 
comparison of four consecutive reconstructions of 80 s time 
frames revealed several topological changes. The enlargements 
on the right show a progressive shift of the plasma membrane 
(Figure 4b1); the formation of a protrusion that could represent 
the genesis of a new branch (Figure 4b2); and deformations of 
two protrusions (Figures 4b3,4). Finally, we could also observe 
phototoxicity-induced cell surface topological changes in cul-
tured hippocampal neurons by exposing the cells to high laser 
powers (50% of max. intensity) at 405 nm, a wavelength known 
to induce phototoxicity. The appearance and steady growth of 
blebs was evidenced in axons (Figure 4c), with a deformation 
rate of around 400 nm in 242 s (or 1.65 nm s−1) as computed 
from the intensity profiles (Figure S4, Supporting Information).
Finally, to demonstrate the versatility of the nanoPaint 
method, we used QDs bound to a protein named “cholera toxin 
B” (CTB), which is known to bind preferentially to lipid gangli-
oside GM1 that is enriched in the axonal compartment.[46] With 
these QD-CTB nanotools, we reconstructed surface topography 
in 3D as done with the anti-CB1 QDs (Figure S6, Supporting 
Information). The image in Figure S6 in the Supporting Infor-
mation corresponds to a reconstruction time of 34 s, 2100 
frames, and a 500 nm depth.
3. Conclusions
Together, these results show that QD bioconjugates recognizing 
epitopes present at the extracellular space of the plasma mem-
brane are effective and simple tools to rapidly (seconds) recon-
struct, in conjunction with SRM, the topology and dynamics of 
the cellular plasma membrane in 3D at a nanoscopic level with 
high temporal-spatial resolution and long-term imaging poten-
tiality. Given the capability of the bioconjugates to access and 
explore the synaptic cleft, a road of opportunities opens up to 
explore nanostructural neuronal plasticity with nanoPaint.
4. Experimental Section
Materials: The materials required for the synthesis of the QD 
nanoparticles and of the QD ligand and the chemicals used for QD 
bioconjugation were as detailed in Tasso et al.[28] Recombinant protein A 
(45 kDa) was purchased from ProSpec as a solution without additives. 
Bis(sulfosuccinimidyl)suberate (BS3) linker and Rabbit polyclonal 
anti-CB1 N-Ter antibody (PA1-743) were purchased from Thermo 
Scientific. Mouse monoclonal anti-FLAG (IgG2) antibody was purchased 
from Sigma-Aldrich. Neurobasal, B-27, and Lipofectamine2000 
Transfection Reagent, Dulbecco’s modified Eagle medium (high 
glucose, GlutaMAX without sodium pyruvate), L-glutamine, fetal 
bovine serum, penicillin-streptomycin (10 000 U mL−1) and Trypsin-
ethylenediaminetetraacetic acid (0.05%) phenol red were obtained from 
Life Technologies. Rabbit anti-N-terminal-CB1 antibody was produced 
by Double-X program (Eurogentec) as detailed in Leterrier et al.[34] 
High precision coverglasses (1.5H) were from Marienfeld Superior. 
Ludin Type 1 chambers were purchased from Life Imaging Services 
(Switzerland).
Quantum Dot Synthesis and Ligand Exchange: Red-emitting 
(λem = 650 nm) CdSe/CdS/ZnS multishell QDs were synthesized 
following published protocols.[30,31] Core/multishell QDs in 
hexane (4 nmol) were precipitated by ethanol addition followed 
by centrifugation (16 000 g, 5 min, unless otherwise stated). After 
supernatant’s removal, QDs were mixed with 3-mercaptopropionic 
acid (MPA, 500 µL) using a sonicating bath and then stored at 60 °C 
for 6–12 h. MPA-capped QDs were resuspended in 1 mL chloroform 
and thereafter precipitated by centrifugation. The obtained QDs 
were dissolved in ≈1 mL dimethylformamide and precipitated by an 
addition of ≈50 mg of potassium tert-butoxide. The suspension was 
afterward centrifuged to remove the basic organic supernatant and 
the nanoparticles were washed twice with ethanol before redispersion 
in 400 µL of 100 × 10−3 m sodium bicarbonate buffer (pH = 10.8). 
Thereafter, the block copolymer ligand (4 mg) was resuspended in 
100 × 10−3 m sodium bicarbonate buffer (200 µL) and added to the 
MPA-QDs dispersion. The nanoparticles were left overnight at room 
temperature to complete the cap exchange. Free ligands were removed 
by two rounds of ultrafiltration (16 000 g, 10 min) in Vivaspin 100 kDa 
membrane filter units (buffer = 100 × 10−3 m NaCl). Polymer-capped 
QDs were thereafter purified by ultracentrifugation (268 000 g, 25 min) 
in a 10–40% sucrose gradient in 100 × 10−3 m NaCl. The QD band was 
collected and sucrose was removed by several rounds of ultrafiltration 
(100 kDa Vivaspin filter, 16 000 g, 10 min). The ligand-exchanged 
nanoparticles were finally resuspended in 600 µL of 50 × 10−3 m  
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 100 × 10−3 m  
NaCl, pH 7.5, and stored at 4 °C in the dark.
Bioconjugation of the QD Nanoparticles: Ligand-capped QDs 
(0.4 nmol) in 100 µL of 50 × 10−3 m HEPES, 100 × 10−3 m NaCl, pH 7.5 
buffer were reacted for 30 min with 0.42 µmol of BS3 (50 mg mL−1 stock 
solution in dimethyl sulfoxide; BS3 molar excess to QDs ≈1000) under 
mixing in a rotating platform. Unreacted BS3 was afterward removed via 
three rounds of membrane filtration (50 kDa Vivaspin filter, 16 000 g, 
7 min) in 50 × 10−3 m HEPES, 100 × 10−3 m NaCl, pH 7 buffer, and the 
linker-modified QDs resuspended in 100 µL of pH 7.5 buffer. Covalent 
binding of an intermediate protein A layer to the linker-modified QDs 
was performed by adding a 10 × molar excess of protein A to the QD 
suspension and by letting the reaction proceed for 1 h under mixing 
in a rotating platform. Here, the total volume was adjusted to yield 
final QD concentrations of 3–4 × 10−6 m. After incubation, unreacted 
protein A was removed via two ultracentrifugation cycles (151 000 g, 
25 min). QD-pA samples were thereafter resuspended in 100 µL of 
pH = 7.5 buffer and mixed with ≈100 µL of buffer-exchanged antibody 
(Ab) (rinsing buffer = 50 × 10−3 m HEPES, 100 × 10−3 m NaCl, pH = 8.5 
adjusted with 2 m NaOH aqueous solution) at a 1:4 QD:Ab ratio. The 
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antibody binding reaction to the QD-pA nanoconstructs was left to 
evolve for 1 h under mixing in a rotating platform. Mouse anti-FLAG 
(IgG2) and rabbit anti-CB1 N-Ter antibodies were used. Unbound 
Ab was not removed and the QD-pA-Ab conjugates (≈1–1.5 × 10−6 m) 
were stored at 4 °C until use without the addition of preservatives or 
other compounds.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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